A broad coalition including health-care providers, insurers and seniors will propose major changes Monday designed to rein in prescription-drug costs, including a shorter exclusivity period for biotech medications and a requirement that manufacturers disclose more information about pricing.
The Campaign for Sustainable Rx Pricing, whose members include AARP, Walmart and several health plans, is trying to stoke interest in the fall elections with an eye toward winning policy changes in 2017. Many of the proposals would require congressional or administrative action and have little chance this year.
Read Full Article »